Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant truncated SPINT2 protease inhibitor |
---|---|
Date Designated: | 06/24/2005 |
Orphan Designation: | Treatment of cystic fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Aerovance, Inc. 2929 Seventh Street Berkeley, California 94710 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-